New Initiative on Aging and Cancer
Targeting the relationship between cancer and aging, the NationalCancer Institute and the National Institute on Aging will jointlyfund a new initiative to investigate the correlation between thetwo. The institutes will provide approximately $25 million in grantsover the 5-year program, with $5 million awarded in the initial year toeight institutions.
Targeting the relationship between cancer and aging, the National Cancer Institute and the National Institute on Aging will jointly fund a new initiative to investigate the correlation between the two. The institutes will provide approximately $25 million in grants over the 5-year program, with $5 million awarded in the initial year to eight institutions. "The need for research at the aging-cancer interface has never been more urgent," NCI said in announcing the initiative. The program's initial grants went to researchers at Case Western Reserve University, Memorial Sloan-Kettering Cancer Center, University of Pittsburgh Cancer Institute, University of Iowa, H. Lee Moffitt Cancer Center, University of Wisconsin, University of Colorado, and University of Washington.
Efficacy and Safety of Zolbetuximab in Gastric Cancer
Zolbetuximab’s targeted action, combined with manageable adverse effects, positions it as a promising therapy for advanced gastric cancer.
These data support less restrictive clinical trial eligibility criteria for those with metastatic NSCLC. This is especially true regarding both targeted therapy and immunotherapy treatment regimens.
